Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-κB pathways.
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-κB pathways.
复制标题
DOI：
10.1007/s00210-017-1417-9
复制
发表时间：
2017
期刊：
影响因子：
--
通讯作者：
Hai Jian
中科院分区：
文献类型：
--
作者：
Su Shao-Hua;Wu Yi-Fang;Lin Qi;Hai Jian
